Scott W. Cousins
About
In The Last Decade
Scott W. Cousins
167 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Ophthalmology 4.7k
- Radiology, Nuclear Medicine and Imaging 2.8k
- Molecular Biology 1.8k
- Immunology 1.0k
- Epidemiology 697
Countries citing papers authored by Scott W. Cousins
This map shows the geographic impact of Scott W. Cousins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott W. Cousins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott W. Cousins more than expected).
Fields of papers citing papers by Scott W. Cousins
This network shows the impact of papers produced by Scott W. Cousins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott W. Cousins. The network helps show where Scott W. Cousins may publish in the future.
Co-authorship network of co-authors of Scott W. Cousins
This figure shows the co-authorship network connecting the top 25 collaborators of Scott W. Cousins. A scholar is included among the top collaborators of Scott W. Cousins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott W. Cousins. Scott W. Cousins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 1 | |
| 3 | Effects of the Mitochondria-Targeted Drug Elamipretide on Leakage-Independent Vision Loss in Fellow Eyes with Neovascular AMD in the ReCLAIM Study | 2 |
| 4 | 81 | |
| 5 | 3 | |
| 6 | 87 | |
| 7 | Use of mobile MyVisionTrack (mVT) technology as a remote visual function metric in Early and Intermediate Age-Related Macular Degeneration | 1 |
| 8 | Indocyanine Green Angiography-Directed Verteporfin Photodynamic Therapy for Treatment of Serous Pigment Epithelium Detachments in Neovascular Age-Related Macular Degeneration | 1 |
| 9 | Neovascular Morphology by ICG Angiography and Response to Loading-Dose Anti-VEGF Therapy in Patients with Neovascular AMD | 2 |
| 10 | Mitochondrial Dysfunction in Experimental Mouse Models of SubRPE Deposit Formation and Reversal by the Mito-Reparative Drug MTP-131 | 7 |
| 11 | Retinal imaging biomarkers for early diagnosis of Alzheimer’s disease | 1 |
| 12 | The mitochondria-targeted peptide MTP-131 prevents hydroquinone-mediated persistent injury phenotype in cultured retinal pigment epithelium cells | 2 |
| 13 | Robust, easy-to-use, semiautomated software quantifies lesion rim area hyperautofluorescence and predicts progression of geographic atrophy. | 1 |
| 14 | Treatment Patterns in Neovascular Age-Related Macular Degeneration between 2005-2010 | 1 |
| 15 | High-speed Indocyanine Green Angiography In Age Related Macular Degeneration With Fibrovascular Pigment Epithelial Detachments | 2 |
| 16 | Lesion Morphology on Indocyanine Green Angiography in Age-Related Macular Degeneration with Classic Choroidal Neovascular Membrane: Implications for Response to anti-VEGF Treatment | 3 |
| 17 | The Effect of -3 and -6 Polyunsaturated Fatty Acid Peroxidation Products on RPE Cell Morphology: Implications for Development of Sub-retinal Deposits in Early AMD | 1 |
| 18 | Effects of Sub-Lethal Levels of Omega-3 and -6 Polyunsaturated Fatty Acid Oxidation End Products in RPE Cell Culture | 1 |
| 19 | Immortalization of Mouse Retinal Pigmented Epithelial Cell Lines:A New Tool to Further Age Related Macular Degeneration Research | 1 |
| 20 | The Big Bar Lake Burial : Middle Period Human Remains from the Canadian Plateau | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.